Repro-T Company

Arlington, MA Doing business as Portal Biotechnologies Portal Biotechnologies

UEI
TQ2TYYVLY216
CAGE
9YMC8
Primary NAICS
339112 Surgical and Medical Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
27 Brunswick Rd, Arlington, MA 02476, USA
Website
oracle.com
Founded
1977
Employees
100K+
Estimated annual revenue
$10B+
Industry
  1. Information Technology
  2. Software & Services
  3. Internet Software & Services
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Repro-T Company's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A high throughput platform for intracellular delivery of impermeable drug molecules and molecular probes to enable a new… Grant · R44TR006374 National Center for Advancing Translational Sciences $1,215,061
DARPA commercial solutions opening - embedded entrepreneur initiative Contract · HR001126CE073 Defense Advanced Research Projects Agency $349,997

Quick answers

What is Repro-T Company's UEI?

Repro-T Company's Unique Entity ID (UEI) in SAM.gov is TQ2TYYVLY216.

What is Repro-T Company's CAGE code?

Repro-T Company's CAGE code is 9YMC8.

What is Repro-T Company's primary NAICS code?

Repro-T Company's primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).

Where is Repro-T Company located?

Repro-T Company's physical address in SAM.gov is 27 Brunswick Rd, Arlington, MA 02476, USA.

Is Repro-T Company registered in SAM.gov?

Yes. Repro-T Company's SAM.gov registration is active through July 7, 2027.

What is Repro-T Company's most recent federal award?

Repro-T Company's most recent federal grant award is A high throughput platform for intracellular delivery of impermeable drug molecules and molecular probes to enable a new… (R44TR006374), from National Center for Advancing Translational Sciences, on September 1, 2026.

On GovTribe

See Repro-T Company's full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login